Histologic Response to UVA and UVB Exposure During the Use of Sunscreen

Solar Elastosis Clinical Trial

Official title:
Histologic Response to UVA and UVB Exposure During the Use of Sunscreen With Anti-inflammatory and Anti-oxidant Properties - A Pilot Study

Status Completed

Clinical Trial Summary

Anti-inflammatory and anti-oxidant agents have become the important ingredients in sunscreen. However, there is no histologic study about the effects of anti-inflammatory and anti-oxidative properties of sunscreen to prevent premature aging from UVA and UVB.

Clinical Trial Description

Premature aging can be prevented by using sunscreen. Currently, anti-inflammatory and anti-oxidant agents have become the important ingredients in sunscreen. However, there is no histologic study about the effects of anti-inflammatory and anti-oxidative properties of sunscreen to prevent premature aging from UVA and UVB. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)

Related Conditions & MeSH terms

Solar Elastosis

Clinical Trial Details

NCT number	NCT01892150
Study type	Interventional
Source	Mahidol University
Contact
Status	Completed
Phase	N/A
Start date	March 2013
Completion date	July 2013

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01529788` - Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study	Phase 4
	Completed	`NCT00843323` - Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin	N/A